Evolving Clinical Features of Diabetic Ketoacidosis: The Impact of SGLT2 Inhibitors

Evolving Clinical Features of Diabetic Ketoacidosis: The Impact of SGLT2 Inhibitors

<b>Background/Objectives</b>: The antidiabetic effect of SGLT2 inhibitors (SGLT2-is) is based on their ability to increase glucose excretion through urine by inhibiting the kidney-resident SGLT2 protein. Euglycemic diabetic ketoacidosis (EuDKA) is an uncommon but potentially life-threate...

Full description

Saved in:
Bibliographic Details
Main Authors: Selin Genc, Bahri Evren, Onur Selcuk Yigit, Ibrahim Sahin, Ramazan Dayanan, Aleksandra Klisic, Ayse Erturk, Filiz Mercantepe
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Pharmaceuticals
Subjects:
diabetic ketoacidosis (DKA)
euglycemic diabetic ketoacidosis (euDKA)
genitourinary infection (GUI)
latent autoimmune diabetes in adults (LADA)
sodium–glucose co-transporter-2 inhibitor (SGLT2-i)
type 1 diabetes mellitus (T1DM)
Online Access:https://www.mdpi.com/1424-8247/17/11/1553
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1424-8247/17/11/1553

Similar Items